Concerns Over Medicare Advantage Raised in Congressional Hearing
During a Congressional hearing on Tuesday, several Republicans voiced criticism regarding Medicare Advantage (MA), suggesting that the privatized program might need a significant overhaul from Washington. Although calling for reforms isn’t new, it’s noteworthy when MA proponents criticize the GOP, especially since the party has historically supported programs that involve private insurers managing care for Medicare beneficiaries.
Medicare Advantage was initially designed to save costs while enhancing outcomes. Yet, critics argue that it’s spiraled out of control, recently pointing out evidence suggesting that MA programs are leading to higher expenses for the government while providing limited healthcare options for seniors.
“We all know there’s a problem,” Rep. Mike Kelly from Pennsylvania remarked at the hearing, emphasizing the impact on people’s health.
The hearing tackled the issue of prior authorizations that were implemented due to high care costs associated with MA plans. Lawmakers also raised concerns regarding increased spending in Massachusetts, particularly tied to a practice known as Upcoding, where insurance companies inflate the reported illnesses of their members to secure higher reimbursements from the government.
According to the Congressional Advisory Group MEDPAC, the federal government is poised to spend an additional $84 billion this year on MA enrollees compared to if these patients were covered by traditional Medicare.
David Schweikert, a Republican from Arizona, expressed his desire for collaboration among party members and agencies to ensure better coordination of incentives, stating, “This is not a game. This is one of the biggest things in our government.”
Major Players Under Scrutiny
At the hearing, major MA insurers faced heavy scrutiny, particularly UnitedHealthcare, which serves 8.2 million beneficiaries. The insurer is at the center of concerns regarding Upcoding, with accusations of profiting billions through these practices.
Among the witnesses, the CEO of Alignment Health Plan and representatives from smaller MA providers received praise from lawmakers for focusing on quality and value instead of prioritizing profits like their larger counterparts. “I commend you for doing it right,” said Rep. Greg Murphy, expressing a wish to see larger insurers like UnitedHealthcare and Humana also held accountable.
However, Republicans acknowledged that making changes to MA may be challenging, given its popularity with older adults and its commitment to enhancing care quality while saving costs.
Rep. Vern Buchanan, also a Republican, remarked, “I think we can ensure that it remains a strong option for beneficiaries while protecting the integrity of MA.”
The Better Medicare Alliance, a key lobby group for MA providers, urged caution before any significant changes, emphasizing the need for thoughtful reforms that reinforce the benefits of the program while safeguarding the affordable, coordinated care that beneficiaries depend on.
Matthew Fiedler from the Brookings Institute noted during the hearing that if changes to MA payments are considered, aligning them with the costs of covering similar enrollees under traditional Medicare should be a priority.
Fiedler stated that modifying the flawed risk adjustment program is a critical step. A witness from a health plan agreed with the need for adjusting risks but cautioned lawmakers against sweeping reforms that could jeopardize the financial stability of all managed care entities.
There was a consensus among witnesses regarding the importance of streamlining and automating the prior authorization process, as well as increasing transparency in approval decisions.
The hearing suggested that addressing problematic behaviors in Massachusetts has emerged as a bipartisan concern. Legislation aimed at reforming MA has been introduced by lawmakers from both parties, with the most recent effort led by Rep. Lloyd Doggett and Rep. Murphy, proposing that MA plans compensate providers similarly to traditional Medicare rates.
Still, many observers doubt that significant healthcare legislation will materialize soon, especially given the recent GOP policy changes, which include over $1 trillion in cuts to healthcare programs, impacting Medicaid and affordable care regulations.
